Showing results (3221-3230 of 6,182) with videos related to
Sort By:
Pageof 619
Nature Medicine|February 28, 2012
NKG2D signaling on CD8⁺ T cells represses T-bet and rescues CD4-unhelped CD8⁺ T cell memory recall but not effector responsesAndrew Zloza, Frederick J Kohlhapp, Gretchen E Lyons, et al.Nature Medicine|February 28, 2012
High abundance of plasma cells secreting transglutaminase 2-specific IgA autoantibodies with limited somatic hypermutation in celiac disease intestinal lesionsRoberto Di Niro, Luka Mesin, Nai-Ying Zheng, et al.Nature Medicine|March 6, 2012
Tyrosine phosphatase SHP2 promotes breast cancer progression and maintains tumor-initiating cells via activation of key transcription factors and a positive feedback signaling loopNicola Aceto, Nina Sausgruber, Heike Brinkhaus, et al.Nature Medicine|September 23, 2008
Cyclophilin D deficiency attenuates mitochondrial and neuronal perturbation and ameliorates learning and memory in Alzheimer's diseaseHeng Du, Lan Guo, Fang Fang, et al.Nature Medicine|September 9, 2008
Endocannabinoid signaling as a synaptic circuit breaker in neurological diseaseIstván Katona, Tamás F FreundNature Medicine|September 25, 2007
In vivo magnetic resonance imaging of acute brain inflammation using microparticles of iron oxideMartina A McAteer, Nicola R Sibson, Constantin von Zur Muhlen, et al.Nature Medicine|July 29, 2008
Hepatocyte-specific ablation of Foxa2 alters bile acid homeostasis and results in endoplasmic reticulum stressIrina M Bochkis, Nir E Rubins, Peter White, et al.Nature Medicine|February 15, 2022
Antibody responses and correlates of protection in the general population after two doses of the ChAdOx1 or BNT162b2 vaccinesJia Wei, Koen B Pouwels, Nicole Stoesser, et al.Nature Medicine|October 8, 2021
Safety, pharmacokinetics and antiviral activity of PGT121, a broadly neutralizing monoclonal antibody against HIV-1: a randomized, placebo-controlled, phase 1 clinical trialKathryn E Stephenson, Boris Julg, C Sabrina Tan, et al.Nature Medicine|February 4, 2022
Safety and immunogenicity of a ferritin nanoparticle H2 influenza vaccine in healthy adults: a phase 1 trialKatherine V Houser, Grace L Chen, Cristina Carter, et al.Pageof 619